Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 354,324 | 395,127 | 379,095 | 383,645 | 359,690 |
| Cost of Goods | 133,476 | 149,462 | 142,636 | 143,671 | 128,912 |
| Gross Profit | 220,848 | 245,665 | 236,459 | 239,974 | 230,778 |
| Operating Expenses | 194,221 | 210,047 | 257,682 | 194,686 | 199,382 |
| Operating Income | 27,103 | 36,080 | -20,587 | 45,959 | 32,308 |
| Interest Expense | 17,752 | 13,462 | 13,962 | 13,384 | 13,149 |
| Other Income | 2,091 | 3,789 | 7,040 | 3,808 | 5,664 |
| Pre-tax Income | 11,442 | 26,407 | -27,509 | 36,383 | 24,823 |
| Income Tax | 2,262 | 11,088 | 101 | 6,647 | -7,933 |
| Net Income Continuous | 9,180 | 15,319 | -27,610 | 29,736 | 32,756 |
| Net Income | $9,180 | $15,319 | $-27,610 | $29,736 | $32,756 |
| EPS Basic Total Ops | 0.11 | 0.18 | -0.32 | 0.35 | 0.38 |
| EPS Basic Continuous Ops | 0.11 | 0.18 | -0.32 | 0.35 | 0.38 |
| EPS Diluted Total Ops | 0.11 | 0.18 | -0.32 | 0.34 | 0.38 |
| EPS Diluted Continuous Ops | 0.11 | 0.18 | -0.32 | 0.34 | 0.38 |
| EBITDA(a) | $63,029 | $65,264 | $8,383 | $74,207 | $60,758 |